ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 138 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,199 | +26.0% | 2,317 | +41.5% | 0.00% | 0.0% |
| Q2 2023 | $46,978 | +19.6% | 1,638 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $39,263 | +27.0% | 1,638 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $30,925 | +28.9% | 1,638 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $24,000 | -4.0% | 1,638 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $25,000 | -43.2% | 1,638 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $44,000 | -27.9% | 1,638 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $61,000 | -21.8% | 1,638 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $78,000 | +41.8% | 1,638 | 0.0% | 0.00% | +50.0% |
| Q2 2021 | $55,000 | -19.1% | 1,638 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $68,000 | -15.0% | 1,638 | -11.2% | 0.00% | -25.0% |
| Q4 2020 | $80,000 | +35.6% | 1,844 | +35.2% | 0.00% | +33.3% |
| Q3 2020 | $59,000 | +9.3% | 1,364 | +18.4% | 0.00% | 0.0% |
| Q2 2020 | $54,000 | – | 1,152 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |